PLK1 and breast carcinoma: Resveratrol impaired the proliferation of breast cancer cells by inducing the hypermethylation of the promoters of the genes of Aurora protein kinase (AURKA) and the Polo-like kinase-1 (PLK1) and consequently decreased its expression (104), reinforcing the potential role of resveratrol in cancer therapy.